Rieko Ohta

Complement-Mediated Mechanisms in Anti-GD2 Monoclonal Antibody Therapy of Murine Metastatic Cancer

Masaki Imai, Charles Landen, Rieko Ohta et al. · Cancer Research · 2005 · 130 citations

Life Sciences, Immunology, Oncology +17

Tissue distribution of products of the mouse decay‐accelerating factor (DAF) genes. Exploitation of a <i>Daf1</i> knock‐out mouse and site‐specific monoclonal antibodies

Feng Lin, Yoshihiro Fukuoka, Andrew P. Spicer et al. · Immunology · 2001 · 98 citations

Life Sciences, Immunology, Molecular Biology +13

Serum concentrations of complement anaphylatoxins and proinflammatory mediators in patients with 2009 H1N1 influenza

Rieko Ohta, Yuka Torii, Masaki Imai et al. · Microbiology and Immunology · 2011 · 70 citations · Full text

Life Sciences, Immunology, Infectious Diseases +14

Characterization of glycosylphosphatidylinositol‐anchored decay accelerating factor (GPI‐DAF) and transmembrane DAF gene expression in wild‐type and GPI‐DAF gene knockout mice using polyclonal and monoclonal antibodies with dual or single specificity

Takashi Miwa, Xiujun Sun, Rieko Ohta et al. · Immunology · 2001 · 48 citations · Full text

Life Sciences, Immunology, Molecular Biology +10

Increased levels of cytokines and high-mobility group box 1 are associated with the development of severe pneumonia, but not acute encephalopathy, in 2009 H1N1 influenza-infected children

Yoshinori Ito, Yuka Torii, Rieko Ohta et al. · Cytokine · 2011 · 47 citations

Veterinary Medicine, Immunology, Infectious Diseases +17